Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Neurosarcoidosis in a patient treated with tumor necrosis factor alpha inhibitors.

× No keyword cloud information.

12 in total

Review 1. Treatment of sarcoidosis -- from a basic science point of view.

Authors: D R Moller
Journal: J Intern Med Date: 2003-01 Impact factor: 8.989

Review 2. Neurosarcoidosis: a review of its intracranial manifestation.

Authors: D A Nowak; D C Widenka
Journal: J Neurol Date: 2001-05 Impact factor: 4.849

3. Neurosarcoidosis in a patient with rheumatoid arthritis during treatment with infliximab.

Authors: Gunnar Sturfelt; Bertil Christensson; Gunnel Bynke; Tore Saxne
Journal: J Rheumatol Date: 2007-11 Impact factor: 4.666

Review 4. Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases.

Authors: Claire Immediato Daïen; Agnes Monnier; Pascal Claudepierre; Arnaud Constantin; Jean-Paul Eschard; Eric Houvenagel; Mahtab Samimi; Stephan Pavy; Edouard Pertuiset; Eric Toussirot; Bernard Combe; Jacques Morel
Journal: Rheumatology (Oxford) Date: 2009-05-07 Impact factor: 7.580

Review 5. Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors.

Authors: Andrew J Solomon; Rebecca I Spain; Michael C Kruer; Dennis Bourdette
Journal: Mult Scler Date: 2011-08-03 Impact factor: 6.312

6. New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication.

Authors: D Tong; N Manolios; G Howe; D Spencer
Journal: Intern Med J Date: 2012-01 Impact factor: 2.048

7. Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil.

Authors: Michael Moravan; Benjamin M Segal
Journal: Neurology Date: 2009-01-27 Impact factor: 9.910

Review 8. Sarcoidosis appearing during anti-tumor necrosis factor alpha therapy: a new "class effect" paradoxical phenomenon. Two case reports and literature review.

Authors: Alfonso Massara; Luigi Cavazzini; Renato La Corte; Francesco Trotta
Journal: Semin Arthritis Rheum Date: 2009-01-15 Impact factor: 5.532

Review 9. Neurosarcoidosis.

Authors: Elyse E Lower; Kenneth L Weiss
Journal: Clin Chest Med Date: 2008-09 Impact factor: 2.878

Review 10. Autoimmune diseases induced by biological agents: a double-edged sword?

Authors: Manuel Ramos-Casals; Candido Diaz-Lagares; Maria-Jose Cuadrado; Munther A Khamashta
Journal: Autoimmun Rev Date: 2009-10-23 Impact factor: 9.754

4 in total

Review 1. A case of neurosarcoidosis secondary to treatment of etanercept and review of the literature.

Authors: Idanis Berrios; Adalia Jun-O'Connell; Sorina Ghiran; Carolina Ionete
Journal: BMJ Case Rep Date: 2015-07-06

2. Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events.

Authors: Amy Kunchok; Allen J Aksamit; John M Davis; Orhun H Kantarci; B Mark Keegan; Sean J Pittock; Brian G Weinshenker; Andrew McKeon
Journal: JAMA Neurol Date: 2020-08-01 Impact factor: 18.302

3. Systemic Sarcoidosis Associated with Certolizumab Pegol Treatment for Rheumatoid Arthritis: A Case Report and Review of the Literature.

Authors: Keigo Koda; Mikio Toyoshima; Tsuyoshi Nozue; Takafumi Suda
Journal: Intern Med Date: 2020-05-08 Impact factor: 1.271

4. Etanercept may induce neurosarcoidosis in a patient treated for rheumatoid arthritis.

Authors: Cécile-Audrey Durel; Elodie Feurer; Jean-Baptiste Pialat; Emilie Berthoux; Roland D Chapurlat; Cyrille B Confavreux
Journal: BMC Neurol Date: 2013-12-28 Impact factor: 2.474

4 in total